How is the Urine Albumin-to-Creatinine Ratio (UACR) test performed in patients with a history of diabetes, hypertension, or kidney disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How UACR Testing is Performed

UACR testing is performed by collecting a random spot urine sample—preferably a first morning void—and measuring both albumin and creatinine concentrations in the same sample, then calculating their ratio (albumin in mg divided by creatinine in grams). 1

Sample Collection Method

  • Collect a random spot urine sample, with first morning void being the preferred specimen because it has the lowest coefficient of variation (31%) and minimizes day-to-day variability 2

  • The sample should ideally be collected at the same time of day, with the patient having not ingested food for at least 2 hours prior to collection to further reduce variability 2

  • Timed or 24-hour urine collections are unnecessary—they are more burdensome and add little to prediction or accuracy compared to spot samples 1

Laboratory Analysis

  • Both albumin and creatinine are measured simultaneously in the same urine sample 1

  • Albumin is typically measured by immunoassay or spectrophotometric dye-binding methods (such as tetrabromophenol blue) 3

  • Creatinine is measured using colorimetric methods (such as the Jaffe assay) 3

  • The ratio is calculated as: UACR (mg/g) = [Urine Albumin (mg/L) ÷ Urine Creatinine (g/L)] 1

Why Creatinine is Measured

  • Creatinine serves solely as a normalization factor to correct for variations in urine concentration due to hydration status—it is not an independent marker of kidney function in this test 2, 4

  • Measuring albumin alone without creatinine is less expensive but susceptible to false-negative and false-positive results due to variable urine dilution 1

Point-of-Care Testing Options

  • Point-of-care (POC) devices are available for UACR testing in settings where laboratory access is limited, such as rural areas or community pharmacies 1

  • POC devices must demonstrate the ability to produce positive results in 85% of people with significant albuminuria (ACR ≥30 mg/g) and maintain appropriate quality standards 1

  • Currently, POC testing for UACR is less widely available than laboratory-based testing, with median testing rates around 53% in US healthcare organizations compared to 90% for serum creatinine 1

Confirmation Requirements

  • Due to high biological variability (>20% between measurements), two out of three specimens collected within a 3-6 month period should show elevated values before confirming persistent albuminuria 1, 2

  • Use first morning void samples for all confirmatory testing 2

Factors That Can Falsely Elevate Results

Before confirming chronic kidney disease, exclude these transient causes that can temporarily elevate UACR 2:

  • Exercise within 24 hours
  • Active urinary tract infection or fever
  • Menstruation
  • Marked hyperglycemia (poorly controlled blood sugar)
  • Congestive heart failure exacerbation
  • Marked uncontrolled hypertension

Result Interpretation

  • Normal: <30 mg/g creatinine 1, 2
  • Moderately increased albuminuria: 30-299 mg/g creatinine 1, 2
  • Severely increased albuminuria: ≥300 mg/g creatinine 1, 2

Clinical Pitfalls to Avoid

  • Do not use dipstick tests for albumin alone—they lack the precision needed for accurate CKD screening and staging 1

  • Do not diagnose albuminuria based on a single elevated measurement—always confirm with repeat testing over 3-6 months 1, 2

  • Do not order 24-hour urine collections for routine screening—they provide no additional accuracy and reduce patient compliance 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Use of Creatinine in Albumin-to-Creatinine Ratio for Kidney Damage Assessment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Elevated Urine Creatinine with Normal Urine Albumin-to-Creatinine Ratio

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is tested for in a Urine Albumin-to-Creatinine Ratio (UACR) test in patients with a history of diabetes, hypertension, or kidney disease?
What is the normal value for urine Albumin-to-Creatinine Ratio (ACR) in adults?
What is the role and interpretation of the Urine Albumin-to-Creatinine Ratio (UACR) in assessing kidney function and detecting kidney disease?
What is the range of proteinuria or albuminuria in a patient with Chronic Kidney Disease (CKD) that requires stricter blood pressure control, typically less than 130/80 mmHg?
What is the management approach for a patient with a high albumin (protein)/creatinine (waste product) ratio in urine, despite normal urine creatinine and albumin levels, potentially indicating impaired renal function?
What are the treatment options for a 31-year-old male with Postural Orthostatic Tachycardia Syndrome (POTS) experiencing erectile dysfunction?
What is the recommended approach to evaluate the association between obesity, measured by body mass index (BMI), waist circumference, and waist-to-height ratio, and the risk of developing diabetes mellitus type 2 in adults with physical and intellectual disabilities?
What is the treatment and management for conjunctivitis in individuals of all ages?
Is a patient with low Thyroid-Stimulating Hormone (TSH) and very low normal Thyroxine (T4) levels likely to have sick euthyroid syndrome?
What is the maximum recommended daily dose of amlodipine (calcium channel blocker) for a patient with hypertension or coronary artery disease, considering potential risk factors such as impaired renal function or older age?
What is the management and diagnostic plan for a 31-year-old male with Postural Orthostatic Tachycardia Syndrome (POTS) and erectile dysfunction?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.